Evidence map›Paper›PMID 37760116›Full record

ArticleBioengineering (Basel, Switzerland)2023

Improved Cartilage Protection with Low Molecular Weight Hyaluronic Acid Hydrogel.

Riley B Brackin, Gail E McColgan, Saitheja A Pucha, Michael A Kowalski, Hicham Drissi, Thanh N Doan, Jay M Patel

Open access · goldAbstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Riley B BrackinAtlanta VA Medical Center, Decatur, GA 30033, USA.ORCID 0000-0001-6324-5070
Gail E McColganAtlanta VA Medical Center, Decatur, GA 30033, USA.
Saitheja A PuchaAtlanta VA Medical Center, Decatur, GA 30033, USA.
Michael A KowalskiAtlanta VA Medical Center, Decatur, GA 30033, USA.
Hicham DrissiAtlanta VA Medical Center, Decatur, GA 30033, USA.
Thanh N DoanAtlanta VA Medical Center, Decatur, GA 30033, USA.
Jay M PatelAtlanta VA Medical Center, Decatur, GA 30033, USA.ORCID 0000-0003-4889-0818
Emory University · US

Funding

Matrix-reinforcing and cell-instructive smart hydrogel for cartilage preservationIK2RX003928 · VA · VETERANS HEALTH ADMINISTRATION · PI Jay M Patel · 2022 to 2026
–
RRD VA IK2 RX003928VA IK2 RX003928
6 · The paper itself

Abstract

Traumatic joint injuries are common, leading to progressive tissue degeneration and the development of osteoarthritis. The post-traumatic joint experiences a pro-inflammatory milieu, initiating a subtle but deteriorative process in cartilage tissue. To prevent or even reverse this process, our group previously developed a tissue-penetrating methacrylated hyaluronic acid (MeHA) hydrogel system, crosslinked within cartilage to restore and/or protect the tissue. In the current study, we further optimized this approach by investigating the impact of biomaterial molecular weight (MW; 20, 75, 100 kDa) on its integration within and reinforcement of cartilage, as well as its ability to protect tissue degradation in a catabolic state. Indeed, the low MW MeHA integrated and reinforced cartilage tissue better than the high MW counterparts. Furthermore, in a 2 week IL-1β explant culture model, the 20 kDa MeHA demonstrated the most protection from biphasic mechanical loss, best retention of proteoglycans (Safranin O staining), and least aggrecan breakdown (NITEGE). Thus, the lower MW MeHA gels integrated better into the tissue and provided the greatest protection of the cartilage matrix. Future work will test this formulation in a preclinical model, with the goal of translating this therapeutic approach for cartilage preservation.

Indexed as

biomaterialscartilagehyaluronic acidjoint preservation

Identifiers

PMID37760116
PMCPMC10525634
OpenAlexW4386222755

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.